U.S. Physical Therapy, Inc. · NYSE:USPH
U.S. Physical Therapy — Investor Presentation (November 2023)
31 slides from U.S. Physical Therapy's investor presentation, November 2023
Slide 1: November 2023
USP PARTNER ~ November 2023
Slide 2: Disclaimer
Disclaimer Forward-Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included are statements relating to opening of new clinics, availability of personnel and reimbursement environment. The forward-looking statements are based o
Slide 3: USPh At a Glance
USPh At a Glance Leading Physical Therapy Company 675 42 Outpatient Physical and State Occupational Therapy Clinics (5) National Footprint (5) Diversified Payor Mix 87% 13% Physical Therapy Injury Prevention Operations % of Revenue(1) Services % of Revenue(1) Attractive Market Dynamics >$30bn >10% U
Slide 4: Expanding National Footprint of Physical Therapy Clinics
Expanding National Footprint of Physical Therapy Clinics 4
Slide 5: Large and Growing Market Opportunity
Large and Growing Market Opportunity $30B+ U.S. rehab market projected to grow to $40B+ by 2025 Favorable demographics – physically active, aging and obese population segments Significant market potential ~50% of Americans over 18 years old develop a musculoskeletal injury that lasts more than 3 mon
Slide 6: Outpatient Clinics are the Leading Setting For Care
Outpatient Clinics are the Leading Setting For Care Orthopedic rehab is the primary driver of physical therapy services, representing approximately 60% of visits Physical Therapy Delivery Mix Outpatient Clinics Hospitals; Home Health Offices of Other State, Local, Physicians and Private 6 Source: “I
Slide 7: Payors See Significant ROI for Physical Therapy
Payors See Significant ROI for Physical Therapy With PT Without PT Hip replacement surgery Hip replacement surgery ($56,000) ($56,000) Inpatient care Inpatient care ($15,000) ($15,000) Outpatient Physical Readmission Readmission Rate of Home Rate of Therapy Clinic 10% 20% Full Recovery Full Recovery
Slide 8: Competitive Landscape
Competitive Landscape Highly fragmented U.S. outpatient rehab market with 37,000+ clinics (1) No company with >10% market share(2) USPh is one of the largest owner/operator of PT clinics USPh is well-positioned to capitalize in a more challenged macro environment 1,900+ 900 675 Clinics(3) Clinics(3)
Slide 9: Growth Strategy
Growth Strategy 1 Drive organic growth through de novo PT/OT clinic openings, utilize true partnership model 2 Maximize profits of existing facilities by growing patient volume, improving pricing, increasing efficiencies and adding programs and services 3 Augment organic growth through strategic acq
Slide 10: Highly Retentive, Partnership Model
Highly Retentive, Partnership Model Specialize in trauma, sports, work-related and pre- and post-surgical cases Partner with experienced physical therapists Drive volume via referrals Augment sales with marketing reps Organic growth includes lower cost de novo start up clinics Strategic acquisitions
Slide 11: USPh Partnership Advantages
USPh Partnership Advantages Accounting Capital and Resources to Enhance Development Rate HR Less Personal Financial Real Estate Risk Construction Aligned Practice Incentives Purchasing Unlimited Earnings Potential Marketing Enhanced Benefits Compliance Package Legal Business Intelligence and Collabo
Slide 12: Acquisition Strategy
Acquisition Strategy Completed more than 50 acquisitions since 2005 ranging in size from 3 to 52 clinics Acquisitions include five industrial injury prevention services businesses Seeking & evaluating M&A transactions is part of USPh’s DNA Acquisition criteria: Owner therapists continue to operate c
Slide 13: New Clinics Since October 31, 2022
New Clinics Since October 31, 2022 From 11/01/2022 – 10/31/2023 ME VT MA CT PA NJ OH MD WV VA NC TN 5 OK AR SC AL GA MS TX LA FL AK 59 clinics added(1) since October 31, 2022 13 (1) Includes de-novo clinics and acquisitions of single and multi-site practices.
Slide 14: Scale Advantages Create a Robust Business Case for Consolidation
Scale Advantages Create a Robust Business Case for Consolidation Referrals Payor Networks Higher likelihood of referrer Increased likelihood of selection for activity and advocacy payor networks Scale is cited as a core criterion by specialty network managers and payors. Some limited ability to
Slide 15: Revenue Mix by Segment and Payor Type
Revenue Mix by Segment and Payor Type Revenue Mix by Segment Type Physical Therapy Revenue Mix by Payor Type Quarter Ended September 30, 2023 Quarter Ended September 30, 2023 6% 10% 47% 13% 87% 34% 3% Private Insurance & Managed Care Physical Therapy Operations Medicaid Industrial Injury Prevention
Slide 16: USPh Physical Therapy Growth Drivers
USPh Physical Therapy Growth Drivers Both prior to and post COVID-19, each driver has shown robust growth Number of Clinics (1) Daily Patient Visits Per Clinic 2012-1Q23: CAGR +4% 2012-1Q23: CAGR +3% 800 35 29.1 28.7 30 672 30 27.6 24.6 700 640 25.9 26.6 591 583 554 591 24.1 25 578 25 22.9 600 540 2
Slide 17: Daily Physical Therapy Volumes Progression
Daily Physical Therapy Volumes Progression Average Visits per Clinic per Day COVID Trough 35 30.0 29.5 29.8 29.5 30.4 29.7 28.8 29.1 30 27.7 27.1 27.9 26.2 25.8 25 20 18.9 15 10 5 0 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 2Q23 3Q23 Continue to see record-high volumes Third Quarte
Slide 18: Physical Therapy Operations
Physical Therapy Operations Annual Gross Margin Percentage Quarterly Gross Margin Percentage 26.0% 26.0% 23.6% 23.8% 24.0% 24.0% 23.1% 22.7% 22.0% 22.0% 22.0% 21.5% 21.0% 20.2% 20.0% 20.0% 20.0% 20.0% 18.7% 18.0% 18.0% 18.0% 16.0% 16.0% 14.0% 14.0% 12.0% 12.0% 2018 2019 2020 2021 2022 Q1 2022Q2 2022
Slide 19: Industrial Injury Prevention
Industrial Injury Prevention Industrial Injury Prevention services include industrial sports medicine and injury prevention; post offer testing; ergonomic services; occupational health and medical services; specialized solutions Since USPh’s initial entry into the Industrial Injury Prevention servic
Slide 20: Industrial Injury Prevention
Industrial Injury Prevention Revenue ($ in millions) EBITDA Margin(1)(%) $90.0 30.0% $80.0 $77.1 25.7% 25.0% 24.4% $70.0 22.4% 20.4% 20.7% $60.0 20.0% $50.0 $43.9 15.0% $39.2 13.3% $40.0 $37.5 $30.0 $25.5 10.0% $20.0 $14.9 5.0% $10.0 $0.0 0.0% 2017 2018 2019 2020 2021 2022 2017 2018 2019 2020 2021 2
Slide 21: Strong Balance Sheet and Capital Allocation Strategy
Strong Balance Sheet and Capital Allocation Strategy Capital Allocation Strategy Liquidity ($ in millions) (as of 9/30/23) $322.8 Acquisitions Debt Management $175.0 Continue fueling a Maintain strategic flexibility highly acquisitive and a conservative growth strategy within a balance sheet fragmen
Slide 22: Executive Management
Executive Management Joined USPh as COO in November 2003 Chris Reading Promoted to CEO and Board in November 2004 Chief Executive Previously Senior Vice President of Operations with HealthSouth, managed over 200 facilities including OP, Officer ASC, DX Imaging and rehab hospital operations B
Slide 23: Summary Investment Highlights
Summary Investment Highlights Publicly-traded, pure play operator of rehab clinics Proven business model, driven by organic growth and acquisitions Significant scale with national footprint Large and growing market / favorable demographics Strong cash flow and balance sheet Attractive Dividend Yield
Slide 24: Appendix
| sph APPENDIX ONE PARTNER a i - | 1
Slide 25: Demonstrated Track Record of Consistent Growth
Demonstrated Track Record of Consistent Growth Over the last decade, USPH has consistently grown, organically and through strategic acquisitions USPH Revenue ($ in millions) 2012-2022: CAGR +8.2% $553 $482 $495 $454 $414 $423 $357 $331 $305 $252 $264 '12 '13 '14 '15 '16 '17 '18 '19 '20 '21 '22 Growt
Slide 26: Third Quarter 2023 and 2022 Results
Third Quarter 2023 and 2022 Results Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands, except per share data) Net revenue $ 150,007 $ 139,602 $ 450,001 $ 411,962 Gross profit 27,929 26,784 90,993 84,193 Operating income 15,881 14,895 52,941 50,007 Net
Slide 27: Segment Information – Third Quarter 2023 and 2022 Results
Segment Information – Third Quarter 2023 and 2022 Results Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands, except percentages) Gross profit $ 27,929 $ 26,784 $ 90,993 $ 84,193 Physical therapy gross profit $ 23,113 $ 21,932 $ 77,796 $ 70,169 Physica
Slide 28: Reconciliation of Non-GAAP Financial Measures – Operating Results
Reconciliation of Non-GAAP Financial Measures – Operating Results Three Months Ended Nine Months Ended September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 (In thousands, except per share data) Operating Results Net income attributable to USPH shareholders $ 9,254 $ 9,557 $ 27
Slide 29: Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA
Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA Three Months Ended Nine Months Ended September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 (In thousands) Adjusted EBITDA Net income attributable to USPH shareholders $ 9,254 $ 9,557 $ 27,583 $ 29,551 Adjustments:
Slide 30: Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA
Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA Year Ended December 31, 2022 2021 2020 Adjusted EBITDA Net income attributable to USPH shareholders $ 32,158 $ 40,831 $ 35,194 Adjustments: Depreciation and amortization 14,743 11,591 10,533 Goodwill impairment 9,112 - 1,859 Change in f
Slide 31: Thank you
USP ONE PARTNER Thank you
U.S. Physical Therapy — Investor Presentation (November 2023) on 6ix